Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 5/2015

01.10.2015 | Short Research Report

Impact of a pharmacotherapy plan to improve adherence for patients with type-2 diabetes and hypertension in a Chilean hospital

verfasst von: Alejandra Soto, Ximena Avila, Pia Cordova, Pola Fernandez, Mariela Lopez, Lorenzo A. Villa, Felipe Morales

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Background Non-adherence to prescribed treatment is a principle cause of treatment failure in patients with chronic diseases, such as type 2 diabetes mellitus (T2DM) and hypertension. Improved patient monitoring and education have been shown to improve adherence and clinical outcomes. Objective This study evaluates the impact of a pharmacotherapy optimization plan centered on patient education that was implemented at a hospital in Arauco, Chile. Methods A prospective study was conducted using 50 randomly selected patients diagnosed with both T2DM and hypertension. Each patient participated in three successive interview sessions over 6 months. At each session, the following variables were evaluated by a pharmacist: blood pressure, HbA1c, adherence to prescribed medication, and patient knowledge of disease. Results Significant decreases were observed for HbA1c (<0.001), and SBP (<0.001), with stronger and more significant decreases observed for females. Patient adherence to prescribed medication also improved, but not significantly. The number of patients with full knowledge of their diseases increased significantly (p < 0.001) from 10 to 66 %. Conclusion This study suggests that the incorporation of a pharmacotherapeutic optimization plan for patients with chronic diseases can have a positive impact on the control of chronic diseases, such as T2DM and hypertension.
Literatur
2.
Zurück zum Zitat Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33(1):74–109.CrossRefPubMed Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33(1):74–109.CrossRefPubMed
4.
Zurück zum Zitat Dunbar-Jacob J, Erlen JA, Schlenk EA, Ryan CM, Sereika SM, Doswell WM. Adherence in chronic disease. Annu Rev Nurs Res. 2000;18:48–90.PubMed Dunbar-Jacob J, Erlen JA, Schlenk EA, Ryan CM, Sereika SM, Doswell WM. Adherence in chronic disease. Annu Rev Nurs Res. 2000;18:48–90.PubMed
5.
Zurück zum Zitat Ministerio de Salud Chile. Guia Clinica Hipertension Arterial Primaria o esencial en personas de 15 años y mas. Clinical guidelines for primary hypertension in patients 15 years and older. Ministerio de Salud, Gobierno de Chile; 2005. Ministerio de Salud Chile. Guia Clinica Hipertension Arterial Primaria o esencial en personas de 15 años y mas. Clinical guidelines for primary hypertension in patients 15 years and older. Ministerio de Salud, Gobierno de Chile; 2005.
6.
Zurück zum Zitat Ministerio de Salud Chile. Guia Clinica Diabetes Mellitus tipo 2. Clinical guidelines for type 2 diabetes mellitus. Ministerio de Salud, Gobierno de Chile; 2010. Ministerio de Salud Chile. Guia Clinica Diabetes Mellitus tipo 2. Clinical guidelines for type 2 diabetes mellitus. Ministerio de Salud, Gobierno de Chile; 2010.
7.
Zurück zum Zitat Castellano JM, Sanz G, Peñalvo JL, Bansilal S, Fernández-Ortiz A, Alvarez L, et al. A polypill strategy to improve adherence: results from the FOCUS project. J Am Coll Cardiol. 2014;64(20):2071–82.CrossRefPubMed Castellano JM, Sanz G, Peñalvo JL, Bansilal S, Fernández-Ortiz A, Alvarez L, et al. A polypill strategy to improve adherence: results from the FOCUS project. J Am Coll Cardiol. 2014;64(20):2071–82.CrossRefPubMed
8.
Zurück zum Zitat Manteuffel M, Williams S, Chen W, Verbrugge RR, Pittman DG, Steinkellner A. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. J Womens Health. 2013;23(2):112–9.CrossRef Manteuffel M, Williams S, Chen W, Verbrugge RR, Pittman DG, Steinkellner A. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. J Womens Health. 2013;23(2):112–9.CrossRef
9.
Zurück zum Zitat de Castro-Cornejo ML, Rico-Herrera L, Padilla-Raygoza N. Effect of educational support on treatment adherence in patients with type 2 diabetes: an experimental study. Enferm Clínica. 2014;24(3):162–7.CrossRef de Castro-Cornejo ML, Rico-Herrera L, Padilla-Raygoza N. Effect of educational support on treatment adherence in patients with type 2 diabetes: an experimental study. Enferm Clínica. 2014;24(3):162–7.CrossRef
10.
Zurück zum Zitat De Vries ST, Keers JC, Visser R, de Zeeuw D, Haaijer-Ruskamp FM, Voorham J, et al. Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes. J Psychosom Res. 2014;76(2):134–8.CrossRefPubMed De Vries ST, Keers JC, Visser R, de Zeeuw D, Haaijer-Ruskamp FM, Voorham J, et al. Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes. J Psychosom Res. 2014;76(2):134–8.CrossRefPubMed
11.
Zurück zum Zitat Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011;33(1):132–40.PubMedCentralCrossRefPubMed Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011;33(1):132–40.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–12.PubMedCentralCrossRefPubMed Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–12.PubMedCentralCrossRefPubMed
Metadaten
Titel
Impact of a pharmacotherapy plan to improve adherence for patients with type-2 diabetes and hypertension in a Chilean hospital
verfasst von
Alejandra Soto
Ximena Avila
Pia Cordova
Pola Fernandez
Mariela Lopez
Lorenzo A. Villa
Felipe Morales
Publikationsdatum
01.10.2015
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 5/2015
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0131-2

Weitere Artikel der Ausgabe 5/2015

International Journal of Clinical Pharmacy 5/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.